A Study of Atorvo+™ in Healthy Adult Participants

Clinical trial NCT06615284 · COMPLETED

Trial details

NCT number: NCT06615284
Sponsor: Indication Bioscience LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Coronary Heart Disease Dyslipidemias

Start date: 2025-01-28
Primary completion: 2025-05-14
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.